396 related articles for article (PubMed ID: 28884937)
41. Vonoprazan: A Review in Helicobacter pylori Infection.
Shirley M
Drugs; 2024 Mar; 84(3):319-327. PubMed ID: 38388872
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter study.
Kakiuchi T; Matsuo M; Endo H; Sakata Y; Esaki M; Noda T; Imamura I; Hashiguchi K; Ogata S; Fujioka Y; Hanada K; Fukuda K; Yoshimura M; Kajiwara T; Yamamoto K; Yamaguchi D; Kawakubo H; Matsunaga T; Sumino M; Matsunaga K; Muro E; Watanabe A; Fujimoto K
J Gastroenterol; 2023 Mar; 58(3):196-204. PubMed ID: 36528706
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety comparison of
Wang Z; Wang F
Therap Adv Gastroenterol; 2022; 15():17562848221125308. PubMed ID: 36268270
[TBL] [Abstract][Full Text] [Related]
44. Safety and effectiveness of vonoprazan-based rescue therapy for
Yu J; Lv YM; Yang P; Jiang YZ; Qin XR; Wang XY
World J Gastroenterol; 2023 May; 29(20):3133-3144. PubMed ID: 37346155
[TBL] [Abstract][Full Text] [Related]
45. Randomized clinical trial: 7-day vonoprazan-based versus 14-day omeprazole-based triple therapy for Helicobacter pylori.
Bunchorntavakul C; Buranathawornsom A
J Gastroenterol Hepatol; 2021 Dec; 36(12):3308-3313. PubMed ID: 34622504
[TBL] [Abstract][Full Text] [Related]
46. Pre-treatment with proton pump inhibitors decreases the success of primary Helicobacter pylori eradication using a vonoprazan-based regimen.
Shinozaki S; Osawa H; Sakamoto H; Hayashi Y; Kobayashi Y; Miura Y; Lefor AK; Yamamoto H
Kaohsiung J Med Sci; 2018 Aug; 34(8):456-460. PubMed ID: 30041763
[TBL] [Abstract][Full Text] [Related]
47. Role of Vonoprazan in
Sugimoto M; Yamaoka Y
Front Pharmacol; 2018; 9():1560. PubMed ID: 30697158
[TBL] [Abstract][Full Text] [Related]
48. A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance.
Adachi K; Kato S; Koshino A; Nagao K; Sugiyama T; Yoshimine T; Yamaguchi Y; Izawa S; Ohashi W; Ebi M; Funaki Y; Ogasawara N; Sasaki M; Kasugai K
Intern Med; 2023 Aug; 62(16):2301-2306. PubMed ID: 36631092
[TBL] [Abstract][Full Text] [Related]
49. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.
Murakami K; Sakurai Y; Shiino M; Funao N; Nishimura A; Asaka M
Gut; 2016 Sep; 65(9):1439-46. PubMed ID: 26935876
[TBL] [Abstract][Full Text] [Related]
50. Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study.
Gunaratne AW; Hamblin H; Clancy A; Magat AJMC; Dawson MVM; Tu J; Borody TJ
Helicobacter; 2021 Oct; 26(5):e12830. PubMed ID: 34247436
[TBL] [Abstract][Full Text] [Related]
51. Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line
Suzuki S; Gotoda T; Kusano C; Ikehara H; Ichijima R; Ohyauchi M; Ito H; Kawamura M; Ogata Y; Ohtaka M; Nakahara M; Kawabe K
Gut; 2020 Jun; 69(6):1019-1026. PubMed ID: 31915235
[TBL] [Abstract][Full Text] [Related]
52. Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial.
Chen C; Zhang D; Huang S; Zeng F; Li D; Zhang X; Chen R; Chen S; Wang J; Bai F
BMC Gastroenterol; 2024 Apr; 24(1):131. PubMed ID: 38609893
[TBL] [Abstract][Full Text] [Related]
53. Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant
Sue S; Suzuki Y; Sasaki T; Kaneko H; Irie K; Komatsu K; Maeda S
J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685510
[TBL] [Abstract][Full Text] [Related]
54. Vonoprazan-amoxicillin dual therapy with different amoxicillin dosages for treatment-naive patients of Helicobacter pylori infection in China: a prospective, randomized controlled study.
Liu Z; Sun D; Kou L; Jia L; Hao J; Zhou J; Zheng W; Gao F; Chen X
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):712-719. PubMed ID: 38526917
[TBL] [Abstract][Full Text] [Related]
55. Comparison of vonoprazan and proton pump inhibitors for eradication of Helicobacter pylori.
Shinozaki S; Nomoto H; Kondo Y; Sakamoto H; Hayashi Y; Yamamoto H; Lefor AK; Osawa H
Kaohsiung J Med Sci; 2016 May; 32(5):255-60. PubMed ID: 27316584
[TBL] [Abstract][Full Text] [Related]
56. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
57. A Potassium-Competitive Acid Blocker-Based Regimen as Second-Line Therapy Improves Helicobacter pylori Eradication.
Nabeta H; Shinozaki S; Abe Y; Koyanagi R; Nakamichi T; Kobayashi Y; Lefor AK; Hirashima H
Digestion; 2020; 101(3):332-338. PubMed ID: 30991394
[TBL] [Abstract][Full Text] [Related]
58. Vonoprazan and amoxicillin dual therapy as the first-line treatment of Helicobacter pylori infection: A systematic review and meta-analysis.
Du RC; Hu YX; Ouyang Y; Ling LX; Xu JY; Sa R; Liu XS; Hong JB; Zhu Y; Lu NH; Hu Y
Helicobacter; 2024; 29(1):e13039. PubMed ID: 38036941
[TBL] [Abstract][Full Text] [Related]
59. Fourth-generation quinolones in the treatment of
An Y; Wang Y; Wu S; Wang YH; Qian X; Li Z; Fu YJ; Xie Y
World J Gastroenterol; 2018 Aug; 24(29):3302-3312. PubMed ID: 30090010
[TBL] [Abstract][Full Text] [Related]
60. Vonoprazan-Based Triple-Therapy Could Improve Efficacy of the Tailored Therapy of Helicobacter pylori Infection.
Shinmura T; Adachi K; Yamaguchi Y; Izawa S; Hijikata Y; Ebi M; Funaki Y; Ogasawara N; Sasaki M; Kasugai K
J Gastrointestin Liver Dis; 2019 Dec; 28(4):389-395. PubMed ID: 31826057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
